Literature DB >> 25733141

Nectins and nectin-like molecules in development and disease.

Kenji Mandai1, Yoshiyuki Rikitake2, Masahiro Mori3, Yoshimi Takai4.   

Abstract

Nectins and nectin-like molecules (Necls)/Cadms are Ca(2+)-independent immunoglobulin superfamily cell adhesion molecules, expressed in most cell types. Nectins mediate not only homotypic but also heterotypic cell-cell adhesion, in contrast to classic cadherins which participate only in homophilic adhesion. Nectins and Necls function in organogenesis of the eye, inner ear, tooth, and cerebral cortex and in a variety of developmental processes including spermatogenesis, axon guidance, synapse formation, and myelination. They are also involved in various diseases, such as viral infection, hereditary ectodermal dysplasia, Alzheimer's disease, autism spectrum disorder, and cancer. Thus, nectins and Necls are crucial for both physiology and pathology. This review summarizes recent advances in research on these cell adhesion molecules in development and pathogenesis.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell adhesion; Necl; Nectin; Nectin-like molecule

Mesh:

Substances:

Year:  2015        PMID: 25733141     DOI: 10.1016/bs.ctdb.2014.11.019

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  42 in total

Review 1.  The emerging role of antibody-drug conjugates in urothelial carcinoma.

Authors:  Michael Lattanzi; Jonathan E Rosenberg
Journal:  Expert Rev Anticancer Ther       Date:  2020-07-21       Impact factor: 4.512

2.  A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target.

Authors:  Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Protein Sci       Date:  2015-07-30       Impact factor: 6.725

3.  Structure of the heterophilic interaction between the nectin-like 4 and nectin-like 1 molecules.

Authors:  Xiao Liu; Tai An; Dongdong Li; Zheng Fan; Pan Xiang; Chen Li; Wenyi Ju; Jianing Li; Gen Hu; Bo Qin; Bin Yin; Justyna Aleksandra Wojdyla; Meitian Wang; Jiangang Yuan; Boqin Qiang; Pengcheng Shu; Sheng Cui; Xiaozhong Peng
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

Review 4.  An emerging tumor invasion mechanism about the collective cell migration.

Authors:  Yang Yang; Hongmei Zheng; Yuting Zhan; Songqing Fan
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 5.  Closing the Gap: Mouse Models to Study Adhesion in Secondary Palatogenesis.

Authors:  K J Lough; K M Byrd; D C Spitzer; S E Williams
Journal:  J Dent Res       Date:  2017-08-17       Impact factor: 6.116

Review 6.  Neural immunoglobulin superfamily interaction networks.

Authors:  Kai Zinn; Engin Özkan
Journal:  Curr Opin Neurobiol       Date:  2017-05-27       Impact factor: 6.627

7.  Differential Contribution of Cadm1-Cadm3 Cell Adhesion Molecules to Peripheral Myelinated Axons.

Authors:  Natasha Sukhanov; Anya Vainshtein; Yael Eshed-Eisenbach; Elior Peles
Journal:  J Neurosci       Date:  2021-01-04       Impact factor: 6.167

8.  Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.

Authors:  Masahiro Maruoka; Shin Kedashiro; Yuki Ueda; Kiyohito Mizutani; Yoshimi Takai
Journal:  J Biol Chem       Date:  2017-03-03       Impact factor: 5.157

9.  PLEKHA7 Recruits PDZD11 to Adherens Junctions to Stabilize Nectins.

Authors:  Diego Guerrera; Jimit Shah; Ekaterina Vasileva; Sophie Sluysmans; Isabelle Méan; Lionel Jond; Ina Poser; Matthias Mann; Anthony A Hyman; Sandra Citi
Journal:  J Biol Chem       Date:  2016-04-04       Impact factor: 5.157

10.  Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.

Authors:  Han Wang; Jianxun Qi; Shuijun Zhang; Yan Li; Shuguang Tan; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.